Comment on: 'Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors' by Giannelou et al: mutations in TRNT1 result in a constitutive activation of type I interferon signalling

Affiliations

• ¹ Paris Descartes University, Sorbonne-Paris-Cité, Imagine Institute, Paris, France.
• ² INSERM UMR 1163, Laboratory of Neurogenetics and Neuroinflammation, Paris, France.
• ³ Paediatric Haematology-Immunologyand Rheumatology Department, Hôpital Universitaire Necker, AP-HP, Paris, France.
• ⁴ General Paediatrics- Infectious Diseases and Internal Medicine Department, Hôpital Robert Debré, AP-HP, Paris, France.
• ⁵ INSERM UMR 1163, Laboratory of Human Lymphohematopoiesis, Imagine Institute, Paris, France.
• ⁶ Immunobiology of Dendritic Cells, Institut Pasteur, Paris, France.
• ⁷ INSERM U1223, Paris, France.
• ⁸ Centre for Translational Research, Institut Pasteur, Paris, France.
• ⁹ Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
• ¹⁰ Centre for Genomic and Experimental Medicine, MRC - Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
• ¹¹ INSERM UMR 1163, Laboratory of Immunogenetics of Paediatric Autoimmunity, Paris, France.